Linked magnolol dimer as a selective PPAR gamma agonist - Structure-based rational design, synthesis, and bioactivity evaluation
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F17%3A10368802" target="_blank" >RIV/00216208:11160/17:10368802 - isvavai.cz</a>
Výsledek na webu
<a href="http://www.nature.com/articles/s41598-017-12628-5" target="_blank" >http://www.nature.com/articles/s41598-017-12628-5</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/s41598-017-12628-5" target="_blank" >10.1038/s41598-017-12628-5</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Linked magnolol dimer as a selective PPAR gamma agonist - Structure-based rational design, synthesis, and bioactivity evaluation
Popis výsledku v původním jazyce
The nuclear receptors peroxisome proliferator-activated receptor gamma (PPAR gamma) and its hetero-dimerization partner retinoid X receptor alpha (RXR alpha) are considered as drug targets in the treatment of diseases like the metabolic syndrome and diabetes mellitus type 2. Effort has been made to develop new agonists for PPAR gamma to obtain ligands with more favorable properties than currently used drugs. Magnolol was previously described as dual agonist of PPAR gamma and RXR alpha. Here we show the structure-based rational design of a linked magnolol dimer within the ligand binding domain of PPAR gamma and its synthesis. Furthermore, we evaluated its binding properties and functionality as a PPAR gamma agonist in vitro with the purified PPAR gamma ligand binding domain (LBD) and in a cell-based nuclear receptor transactivation model in HEK293 cells. We determined the synthesized magnolol dimer to bind with much higher affinity to the purified PPAR gamma ligand binding domain than magnolol (K-i values of 5.03 and 64.42 nM, respectively). Regarding their potency to transactivate a PPAR gamma-dependent luciferase gene both compounds were equally effective. This is likely due to the PPAR gamma specificity of the newly designed magnolol dimer and lack of RXRa-driven transactivation activity by this dimeric compound.
Název v anglickém jazyce
Linked magnolol dimer as a selective PPAR gamma agonist - Structure-based rational design, synthesis, and bioactivity evaluation
Popis výsledku anglicky
The nuclear receptors peroxisome proliferator-activated receptor gamma (PPAR gamma) and its hetero-dimerization partner retinoid X receptor alpha (RXR alpha) are considered as drug targets in the treatment of diseases like the metabolic syndrome and diabetes mellitus type 2. Effort has been made to develop new agonists for PPAR gamma to obtain ligands with more favorable properties than currently used drugs. Magnolol was previously described as dual agonist of PPAR gamma and RXR alpha. Here we show the structure-based rational design of a linked magnolol dimer within the ligand binding domain of PPAR gamma and its synthesis. Furthermore, we evaluated its binding properties and functionality as a PPAR gamma agonist in vitro with the purified PPAR gamma ligand binding domain (LBD) and in a cell-based nuclear receptor transactivation model in HEK293 cells. We determined the synthesized magnolol dimer to bind with much higher affinity to the purified PPAR gamma ligand binding domain than magnolol (K-i values of 5.03 and 64.42 nM, respectively). Regarding their potency to transactivate a PPAR gamma-dependent luciferase gene both compounds were equally effective. This is likely due to the PPAR gamma specificity of the newly designed magnolol dimer and lack of RXRa-driven transactivation activity by this dimeric compound.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30104 - Pharmacology and pharmacy
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2017
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Scientific Reports
ISSN
2045-2322
e-ISSN
—
Svazek periodika
7
Číslo periodika v rámci svazku
October
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
10
Strana od-do
—
Kód UT WoS článku
000413357100001
EID výsledku v databázi Scopus
2-s2.0-85031895411